SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-000875
Filing Date
2023-05-04
Accepted
2023-05-04 08:31:03
Documents
44
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clrb-20230331x10q.htm   iXBRL 10-Q 699771
2 EX-31.1 clrb-20230331xex31d1.htm EX-31.1 11406
3 EX-31.2 clrb-20230331xex31d2.htm EX-31.2 11404
4 EX-32.1 clrb-20230331xex32d1.htm EX-32.1 8915
  Complete submission text file 0001410578-23-000875.txt   3275781

Data Files

Seq Description Document Type Size
5 EX-101.SCH clrb-20230331.xsd EX-101.SCH 26220
6 EX-101.CAL clrb-20230331_cal.xml EX-101.CAL 24657
7 EX-101.DEF clrb-20230331_def.xml EX-101.DEF 112359
8 EX-101.LAB clrb-20230331_lab.xml EX-101.LAB 228622
9 EX-101.PRE clrb-20230331_pre.xml EX-101.PRE 182329
38 EXTRACTED XBRL INSTANCE DOCUMENT clrb-20230331x10q_htm.xml XML 434376
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36598 | Film No.: 23886697
SIC: 2834 Pharmaceutical Preparations